seed
Stage
2
Investors
About
OrisDX develops a non-invasive, saliva-based diagnostic test to detect early markers of oral cancer, enabling early clinical intervention and improved patient outcomes.
Explore OrisDX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.